Skip to main content
NCI protocol 10250: A phase II study of temozolomide and olaparib for the treatment of advanced uterine leiomyosarcoma. Ingham, M., Allred, J. B., Gano, K., George, S., Attia, S., Burgess, M., Seetharam, M., Boikos, S., Bui, N., Chen, J., Close, J., Cote, G., Thaker, P. H., Ivy, S., Das, B., Shapiro, G., Kochupurakkal, B., Trepel, J. B., Pommier, Y., Schwartz, G. K. LIPPINCOTT WILLIAMS & WILKINS. 2021

View details for DOI 10.1200/JCO.2021.39.15_suppl.11506

View details for Web of Science ID 000708120606043